The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-α-induced depression
Open accessAbstract
The mechanisms by which administration of interferon-α induces neuropsychiatric side effects, such as depressive symptoms and changes in cognitive function, are not clear as yet. Direct influence on serotonergic neurotransmission may contribute to these side effects. In addition, the enzyme indoleamine 2,3-dioxygenase (IDO), which converts tryptophan into kynurenine, may play an important role, first, because IDO activation leads to reduced levels of tryptophan, the precursor of serotonin (5-HT), and thus to reduced central 5-HT synthesis. Second, kynurenine metabolites such as 3-hydroxy-kynurenine (3-OH-KYN) and quinolinic acid (QUIN) have toxic effects on brain function. 3-OH-KYN is able to produce oxidative stress by increasing the production of reactive oxygen species (ROS), and QUIN may produce overstimulation of hippocampal N-methyl-d-aspartate (NMDA) receptors, which leads to apoptosis and hippocampal atrophy. Both ROS overproduction and hippocampal atrophy caused by NMDA overstimulation have been associated with depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Lipid peroxidation and antioxidants as biomarkers of tissue damage
Gutteridge, J. M. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.12.1819 · Cited by 1,844
Hippocampal Volume Reduction in Major Depression
Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., & Charney, D. S. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.115 · Cited by 1,670
Sheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382 · cited 1×
“Major depression is associated with hippocampal volume loss.(78,79) Hypothalamic-pituitary-adrenal (HPA) axis inhibition appears to be mediated by negative feedback from circulating glucocorticoids.”
BackgroundQuinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
Relationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolism
Taylor, M. W., & Feng, G. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.11.1907934 · Cited by 1,060
Evidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Self-citationRole of 5-HT in stress, anxiety, and depression
Graeff, F. G., Guimarães, F. S., De Andrade, T. G. C. S., & Deakin, J. F. W. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02135-3 · Cited by 984
Sickness behavior as a new target for drug development
Kent, S., Bluthé, R.-M., Kelley, K. W., & Dantzer, R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90012-u · Cited by 863
Perkins, M. N., & Stone, T. W. (1982) · Brain Research · doi:10.1016/0006-8993(82)91048-4 · Cited by 849
Endogenous kynurenines as targets for drug discovery and development
Stone, T. W., & Darlington, L. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd870 · Cited by 768
Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism
Fukui, S., Schwarcz, R., Rapoport, S. I., Takada, Y., & Smith, Q. R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03460.x · Cited by 761
Bilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718
HEYES, M. P., SAITO, K., CROWLEY, J. S., DAVIS, L. E., DEMITRACK, M. A., DER, M., DILLING, L. A., ELIA, J., KRUESI, M. J. P., LACKNER, A., et al. (1992) · Brain · doi:10.1093/brain/115.5.1249 · Cited by 680
Sargent, P. A., Kjaer, K. H., Bench, C. J., Rabiner, E. A., Messa, C., Meyer, J., Gunn, R. N., Grasby, P. M., & Cowen, P. J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.2.174 · Cited by 642
Effects of adverse experiences for brain structure and function
McEwen, B. S. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00964-1 · Cited by 639
Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Comparison of stressors
Magarin˜os, A. M., & McEwen, B. S. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00256-i · Cited by 571
Stress-restress: Effects on ACTH and fast feedback
Liberzon, I., Krstov, M., & Young, E. A. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00044-9 · Cited by 556
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 538
Takikawa, O., Kuroiwa, T., Yamazaki, F., & Kido, R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77982-4 · Cited by 472
Okuda, S., Nishiyama, N., Saito, H., & Katsuki, H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010299.x · Cited by 462
Bonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Verkerk, R., Meltzer, H., & Maes, M. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00014 · Cited by 437
Self-citationMaes, M., Smith, R., Christophe, A., Cosyns, P., Desnyder, R., & Meltzer, H. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00092-5 · Cited by 417
Self-citationHartley, D., Kurth, M., Bjerkness, L., Weiss, J., & Choi, D. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-05-01993.1993 · Cited by 389
Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites
Moroni, F. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00196-x · Cited by 346
Lesch, K.-P., & Mössner, R. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00121-8 · Cited by 334
Kynurenine pathway abnormalities in Parkinson's disease
Ogawa, T., Matson, W. R., Beal, M. F., Myers, R. H., Bird, E. D., Milbury, P., & Saso, S. (1992) · Neurology · doi:10.1212/wnl.42.9.1702 · Cited by 315
Kynurenines in the CNS: from endogenous obscurity to therapeutic importance
Stone, T. W. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00032-0 · Cited by 306
Loss of Glucocorticoid Fast Feedback in Depression
Young, E. A. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810320017003 · Cited by 298
Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus
Bonaccorso, S., Marino, V., Biondi, M., Grimaldi, F., Ippoliti, F., & Maes, M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00264-1 · Cited by 284
Self-citationNeuropsychiatric Manifestations of Human Leukocyte Interferon Therapy in Patients With Cancer
Adams, F. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03350070056026 · Cited by 260
Possible mechanisms for atrophy of the human hippocampus
McEwen, B. S. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000254 · Cited by 243
Behan, W. M. H., McDonald, M., Darlington, L. G., & Stone, T. W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702940 · Cited by 225
Fujigaki, S., Saito, K., Sekikawa, K., Tone, S., Takikawa, O., Fujii, H., Wada, H., Noma, A., & Seishima, M. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200108)31:8<2313::aid-immu2313>3.0.co;2-s · Cited by 213
Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease
Guillemin, G. J., & Brew, B. J. (2002) · Redox Report · doi:10.1179/135100002125000550 · Cited by 212
Maes, M., Verkerk, R., Bonaccorso, S., Ombelet, W., Bosmans, E., & Scharpé, S. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01853-2 · Cited by 203
Self-citationBluthé, R. M., Pawlowski, M., Suarez, S., Parnet, P., Pittman, Q., Kelley, K. W., & Dantzer, R. (1994) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)90009-4 · Cited by 203
3‐Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum
Guidetti, P., & Schwarcz, R. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00806.x · Cited by 180
Sanni, L. A., Thomas, S. R., Tattam, B. N., Moore, D. E., Chaudhri, G., Stocker, R., & Hunt, N. H. (1998) · Europe PMC (PubMed Central) · Cited by 178
A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma
Recht, M., Borden, E. C., & Knight, E. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2617 · Cited by 177
Brain Serotonin2 Receptors in Major Depression: A Positron Emission Tomography Study
Yatham, L. N., Liddle, P. F., Shiah, I.-S., Scarrow, G., Lam, R. W., Adam, M. J., Zis, A. P., & Ruth, T. J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.9.850 · Cited by 170
Saito, K., Nowak, T. S., Markey, S. P., & Heyes, M. P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05836.x · Cited by 166
Maes, M., Meltzer, H. Y., Scharpè, S., Bosmans, E., Suy, E., De Meester, I., Calabrese, J., & Cosyns, P. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90102-m · Cited by 161
Self-citationPattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia
Pavol, M. A., Meyers, C. A., Rexer, J. L., Valentine, A. D., Mattis, P. J., & Talpaz, M. (1995) · Neurology · doi:10.1212/wnl.45.5.947 · Cited by 160
Morikawa, O., Sakai, N., Obara, H., & Saito, N. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00187-3 · Cited by 160
Sapolsky, R. M., Meaney, M. J., & McEwen, B. S. (1985) · Developmental Brain Research · doi:10.1016/0165-3806(85)90261-5 · Cited by 158 · cited 1×
“Hypothalamic-pituitary-adrenal (HPA) axis inhibition appears to be mediated by negative feedback from circulating glucocorticoids.(80) Destruction of the hippocampus attenuates the negative feedback via loss of glucocorticoid receptors, which will increase HPA activity.”
BackgroundEffect of oxidative stress on receptors and signal transmission
van der Vliet, A., & Bast, A. (1992) · Chemico-Biological Interactions · doi:10.1016/0009-2797(92)90055-p · Cited by 157
Regulation of the Human Serotonin Transporter by Interleukin-1β
Ramamoorthy, S., Ramamoorthy, J. D., Prasad, P. D., Bhat, G. K., Mahesh, V. B., Leibach, F. H., & Ganapathy, V. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2659 · Cited by 156
Quinolinic acid induces oxidative stress in rat brain synaptosomes
Santamaría, A., Galván‐Arzate, S., Lisý, V., Ali, S. F., Duhart, H. M., Osorio‐Rico, L., Ríos, C., & Sut'astný, F. (2001) · Neuroreport · doi:10.1097/00001756-200103260-00049 · Cited by 152
Sapolsky, R. M., Krey, L. C., & McEwen, B. S. (1986) · Neurobiology of Aging · doi:10.1016/0197-4580(86)90159-4 · Cited by 152
Prefrontal cortical hypometabolism during low-dose interferon alpha treatment
Juengling, F. D., Ebert, D., Gut, O., Engelbrecht, M. A., Rasenack, J., Nitzsche, E. U., Bauer, J., & Lieb, K. (2000) · Psychopharmacology · doi:10.1007/s002130000549 · Cited by 149
Quinolinic Acid Production by Macrophages Stimulated with IFN-γ, TNF-α, and IFN-α
PEMBERTON, L. A., KERR, S. J., SMYTHE, G., & BREW, B. J. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.589 · Cited by 149
Mößner, R. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00026-6 · Cited by 130
Atlante, A., Gagliardi, S., Minervini, G. M., Ciotti, M. T., Marra, E., & Calissano, P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052038.x · Cited by 126
Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages
Chiarugi, A., Calvani, M., Meli, E., Traggiai, E., & Moroni, F. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00418-0 · Cited by 125
Speciale, C., Hares, K., Schwarcz, R. M., & Brookes, N. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-06-02066.1989 · Cited by 110
Brain Quinolinic Acid in Huntington's Disease
Reynolds, G. P., Pearson, S. J., Halket, J. M., & Sandier, M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb02503.x · Cited by 109
Moroni, F., Lombardi, G., Moneti, G., & Aldinio, C. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90385-9 · Cited by 109
Krueger, J. M., Takahashi, S., Kapás, L., Bredow, S., Roky, R., Fang, J., Floyd, R. A., Renegar, K. B., Guha‐Thakurta, N., Novitsky, S. V., et al. (1995) · Advances in Neuroimmunology · doi:10.1016/0960-5428(95)00007-o · Cited by 100
Guillemin, G. J., Kerr, S. J., Pemberton, L. A., Smith, D. G., Smythe, G. A., Armati, P. J., & Brew, B. J. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/107999001317205231 · Cited by 95
Heyes, M. P., Jordan, E. K., Lee, K., Saito, K., Frank, J. A., Snoy, P. J., Markey, S. P., & Gravell, M. (1992) · Brain Research · doi:10.1016/0006-8993(92)90587-y · Cited by 92
3-Hydroxykynurenine Toxicity on the Rat Striatum In Vivo
Nakagami, Y., Saitō, H., & Katsuki, H. (1996) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.71.183 · Cited by 88
Brain Neurotransmission during Peripheral Inflammationa
Linthorst, A. C. E., & Reul, J. M. H. M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09558.x · Cited by 87
Sinz, E. H., Kochanek, P. M., Heyes, M. P., Wisniewski, S. R., Bell, M. J., Clark, R. S. B., DeKosky, S. T., Blight, A. R., & Marion, D. W. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199806000-00002 · Cited by 83
Wu, H., Guidetti, P., Goodman, J. H., Varasi, M., Ceresoli‐Borroni, G., Speciale, C., Scharfman, H. E., & Schwarcz, R. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00030-0 · Cited by 80
Bianchi, M., Sacerdote, P., Ricciardi‐Castagnoli, P., Mantegazza, P., & Panerai, A. E. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90808-k · Cited by 72
Dang, Y.-H., Dale, W. E., & Brown, O. R. (2000) · Free Radical Biology & Medicine · doi:10.1016/s0891-5849(99)00272-5 · Cited by 72
Lacosta, S., Merali, Z., & Anisman, H. (1998) · Psychopharmacology · doi:10.1007/s002130050630 · Cited by 71
Charlton, B. G. (2000) · Medical Hypotheses · doi:10.1054/mehy.1999.0986 · Cited by 69
INCREASED BRAIN 3-HYDROXYKYNURENINE IN HUNTINGTON'S DISEASE
Reynolds, G. P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90987-2 · Cited by 66
Heyes, M. P., Saito, K., Milstien, S., & Schiff, S. J. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00164-w · Cited by 62
Familial LCAT deficiency and fish‐eye disease
McIntyre, N. (1988) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01800570 · Cited by 60
Kynurenine in blood plasma and DST in patients with endogenous anxiety and endogenous depression
Orlikov, A. B., Prakh'e, I. B., & Ryzhov, I. V. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91189-4 · Cited by 60
Heyes, M. P., Wyler, A. R., Devinsky, O., Yergey, J. A., Markey, S. P., & Nadi, N. S. (1990) · Epilepsia · doi:10.1111/j.1528-1167.1990.tb06302.x · Cited by 60
Effects of Chronic Administration of Interferon α A/D on Serotonergic Receptors in Rat Brain
Abe, S., Hori, T., Suzuki, T., Baba, A., Shiraishi, H., & Yamamoto, T. (1999) · Neurochemical Research · doi:10.1023/a:1020929415443 · Cited by 53
Acute interferon-α administration modulates sucrose consumption in the rat
Sammut, S., Goodall, G., & Muscat, R. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(00)00051-2 · Cited by 52
Combination Therapy with Interferon-?? and Ribavirin for Hepatitis C
Collier, J. D., & Chapman, R. W. (2001) · BioDrugs · doi:10.2165/00063030-200115040-00003 · Cited by 46
The "kynurenine shunt" and depression.
Mangoni, A. (1974) · PubMed · Cited by 39
U50,488 protection against HIV-1-related neurotoxicity: involvement of quinolinic acid suppression
Chao, C. C., Hu, S., Gekker, G., Lokensgard, J. R., Heyes, M. P., & Peterson, P. K. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00063-5 · Cited by 34
An exploratory approach to the serotonergic hypothesis of depression: bridging the synaptic gap
Dursun, S. M., Blackburn, J., & Kutcher, S. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1187 · Cited by 32
Kazda, H., Taylor, N., Healy, D., & Walker, D. W. (1998) · Pediatric Research · doi:10.1203/00006450-199809000-00017 · Cited by 29
Jansen, M., & Reinhard, J. F. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.4.439 · Cited by 22
Issa, F., Kirch, D. G., Gerhardt, G. A., Bartko, J. J., Suddath, R. L., Freedman, R., & Wyatt, R. J. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90070-1 · Cited by 17
Effect of interferon-? on DOI-induced wet-dog shakes in rats
Kugaya, A., Kagaya, A., Uchitomi, Y., Yokota, N., & Yamawaki, S. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291785 · Cited by 14
Research works printed but not linked: 5
- Qin ZH, 1996, Brain Res, 725, 166
- Heyes MP, 1998, FASEB J, 12, 881
- Sanni LA, 1998, Am J Pathol, 152, 611
- Mangoni A, 1974, Adv Biochem Psychopharmacol, 11, 293
- Maes M, 1995, Psychopharmacology, 933
Cited by
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Self-citationKorte, S. M., Koolhaas, J. M., Wingfield, J. C., & McEwen, B. S. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.08.009 · Cited by 1,097
Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9118-1 · Cited by 894
Self-citationLeonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
Self-citationMaes, M., Leonard, B. E., Myint, A. M., Kubera, M., & Verkerk, R. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.017 · Cited by 700
Self-citation
Metadata
- Authors
- Wichers, M. C., & Maes, M.
- Venue
- Journal of Psychiatry and Neuroscience
- Publisher
- Canadian Science Publishing
- Published
- 2004-01
- Volume
- 29
- Issue
- 1
- Pages
- 11-17
- ISSN
- 1180-4882 (ISSN-L)
- 1488-2434
- OpenAlex
- W4413979613
- Cited by
- 285
- References
- 84
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.